Based on our previous in vitro studies and on the current results, we can propose that cathepsin X is an important causative factor in neurodegenerative processes, resulting in progressive loss of dopaminergic neurons, and is therefore designated as a potential target for therapeutic interventions in PD. Here, CTSZ is linked to Parkinson disease.